What do peptides do depends on the sequence, because peptides are a chemical class with a very wide range of functions. In living organisms they act as hormones, neurotransmitters, growth factors and defence molecules, mostly by binding receptors on cell surfaces and triggering signalling cascades. In laboratories, synthetic peptides serve as receptor ligands, enzyme substrates, antigens and analytical standards. This article explains the biology, describes the main laboratory uses, summarises the landmark research, and sets out the analytical and storage standards that make peptide experiments reproducible. It concerns laboratory research only and gives no guidance on use in people.
What are peptides, and what do peptides do in biology?
A peptide is a molecule made of amino acids joined by amide bonds. The boundary with proteins is conventional, and chains of up to roughly fifty residues are usually called peptides. The smallest, a dipeptide, has two residues. Many biologically important examples are short. Oxytocin has nine residues, vasopressin nine, and glutathione three. Insulin has two chains of 21 and 30 residues linked by disulphide bonds.
In an organism, peptides do four broad things. The first is hormonal signalling. A peptide hormone released from one tissue travels through the blood and binds receptors on target cells elsewhere, so that a small quantity of molecule coordinates the activity of distant tissues. Insulin, glucagon and the incretin hormones are standard examples in textbook physiology, and they regulate how the body handles nutrients.
The second is neurotransmission and neuromodulation. Neuropeptides such as the enkephalins and substance P are released by neurons and modulate signalling between cells. Their effects are usually slower and longer lasting than those of small-molecule neurotransmitters.
The third is host defence. Antimicrobial peptides are produced by many organisms, including humans, and are often cationic and amphipathic, which lets them insert into and disrupt microbial membranes.
The fourth is local regulation and tissue signalling. Fragments released from larger proteins can act as signals, and peptides contribute to processes such as blood pressure regulation and immune communication.
These descriptions are biology and do not imply that any synthetic research peptide has a particular effect in people. Evidence from cell and animal studies does not transfer from one sequence to another, or from a laboratory model to a person, and research-grade peptides have not been assessed by any regulator for human use.
How peptides act at the molecular level
The mechanisms by which peptides act fall into a small number of classes, and understanding them explains how laboratories use peptides.
The most common is receptor binding. Most peptide hormones act on G protein-coupled receptors (GPCRs), which sit in the cell membrane. When the peptide binds, the receptor changes shape and activates intracellular G proteins. Depending on the receptor, the response may raise or lower cyclic AMP, mobilise calcium from intracellular stores or recruit regulatory proteins such as arrestins. Many peptide receptors belong to the class B family, which use a two-site binding mechanism in which the C-terminal part of the peptide engages a large extracellular domain and the N-terminal part inserts into the transmembrane core to trigger activation.
A second class is enzyme interaction. A short peptide can mimic the sequence an enzyme recognises, so it can act as a substrate, which is used to measure enzyme activity, or as a competitive inhibitor, which blocks the active site.
A third is membrane interaction. Antimicrobial peptides and cell-penetrating peptides interact with lipid bilayers, though the detailed mechanisms of membrane crossing are still debated.
A fourth is molecular recognition. Antibodies and T-cell receptors bind short sequences called epitopes, and synthetic peptides are the standard tool for mapping and testing those interactions.
One feature unites these mechanisms in practice. Native peptides are usually short-lived. Proteases in blood and in cell culture media cleave them within minutes, and peptides adsorb to plastic and glass at low concentrations. The effective concentration in an experiment can therefore differ from the nominal one, and the identity, purity and handling of the starting material shape the result.
What the research shows
The history of peptide science is documented in primary literature that can be read directly. Four areas are summarised below in general terms. Readers should consult the original papers for methods and data.
The first is the sequencing of insulin. Frederick Sanger and colleagues, working in Cambridge, determined the amino acid sequence of the two chains of bovine insulin in the early 1950s using chemical degradation and chromatography. The work showed that a protein hormone has a precise, reproducible sequence and earned Sanger the 1958 Nobel Prize in Chemistry. The primary papers can be found through a PubMed search for Sanger insulin sequence papers.
The second is the first chemical synthesis of a peptide hormone. Vincent du Vigneaud and colleagues reported the synthesis of oxytocin in 1953, work recognised with the 1955 Nobel Prize in Chemistry. It showed that a biologically active peptide could be made in a laboratory and that the synthetic product matched the natural hormone in activity.
The third is the development of solid-phase synthesis. Bruce Merrifield described the method in a 1963 paper in the Journal of the American Chemical Society, anchoring the growing chain to a resin so that reagents and by-products could be removed by washing. Later refinements, including Fmoc chemistry, made automated synthesis routine. The quality implications are discussed in the methods literature, which can be reached through a PubMed search on solid-phase peptide synthesis impurities.
The fourth is the structural biology of peptide receptors. Cryo-electron microscopy studies of class B GPCRs bound to peptide agonists have shown how the N-terminal region of a peptide activates its receptor and how the extracellular domain captures the C-terminal region. This work explains, at atomic resolution, how a peptide produces a cellular response.
A common thread is that outcomes depend on the exact chemistry of the material. Papers that omit sequence, salt form, purity and net peptide content are harder to reproduce, which is why analytical characterisation has become a routine expectation.
Research applications: what peptides do in the laboratory
In the laboratory, synthetic peptides are used for tasks that follow directly from the mechanisms above.
In receptor pharmacology, peptides serve as reference agonists and antagonists. They are applied to receptor-expressing cells, and responses such as cyclic AMP accumulation, calcium flux or reporter gene activity give concentration-response curves from which potency and efficacy are calculated. This is how new ligands are benchmarked.
In immunology, overlapping peptide pools spanning a protein are used to stimulate T cells and map epitopes, and peptides coupled to carrier proteins are used to raise antibodies. Peptide arrays map where antibodies bind.
In biochemistry, fluorogenic or chromogenic peptide substrates report protease and kinase activity, and peptide inhibitors are used to dissect pathways.
In structural biology, peptides are used in NMR and crystallography to study folding, binding and aggregation. Amyloid-forming peptides are a standard model for aggregation research.
In analytical chemistry, isotope-labelled peptides serve as internal standards for quantitative proteomics, and characterised reference peptides support method development in liquid chromatography and mass spectrometry.
In peptide chemistry itself, researchers study how modifications such as cyclisation, D-amino acids, lipidation and N-terminal capping alter stability and receptor binding, which is how many current peptide drug candidates were designed.
Different applications call for different specifications. Receptor pharmacology commonly expects purity of at least 95 per cent, and often 98 per cent or higher, with a defined salt form and, for immune cells, a low endotoxin level. Antibody production depends more on correct sequence, and desalted grades are often adequate. Analytical reference work depends on identity and traceability.
Work involving animals in the United Kingdom requires authorisation under the Animals (Scientific Procedures) Act 1986, with personal and project licences and local ethical review. Holding a peptide in a laboratory does not remove that requirement, and research peptides are not authorised medicines for human or veterinary use.
How quality shapes what peptides do in an experiment
What a peptide does in an assay depends on what the vial contains. Four mechanisms explain most of the ways poor material distorts results.
The first is receptor-level interference. A truncated or deletion peptide can keep affinity for the receptor while having lower efficacy, so it behaves as a partial agonist or weak antagonist, shifting the apparent potency and flattening the curve. A preparation that is 80 per cent pure and nominally 10 micromolar contains about 8 micromolar of the intended peptide, plus an uncharacterised mixture.
The second is the counterion. Peptides purified with trifluoroacetic acid (TFA) are normally supplied as TFA salts, and the counterion can be a large share of the powder’s mass. TFA is not biologically neutral at every concentration, and cell-culture work has reported effects on proliferation, so the salt form should be stated.
The third is endotoxin. Bacterial lipopolysaccharide can contaminate reagents, and trace amounts trigger strong responses in immune cells, so an endotoxin-contaminated peptide can appear to be a potent stimulus when the peptide itself is inactive.
The fourth is chemical degradation. Oxidised methionine, deamidated asparagine and isomerised aspartate create species that differ from the intended peptide in charge, shape and binding, and they can arise during storage even when the original chromatogram was clean.
The UK legal and regulatory frame
UK law does not regulate peptides as a chemical class. Under the Human Medicines Regulations 2012, a product can be treated as a medicinal product if it is presented as treating or preventing disease, or if it can be used to modify physiological functions in people, whatever its label says. The Medicines and Healthcare products Regulatory Agency (MHRA) judges products by their overall presentation, and a “research use only” statement does not by itself settle the question. Some individual compounds also fall under controlled-drug legislation or appear on anti-doping lists, and these should be checked against current sources. This is general information and not legal advice.
For a laboratory, the practical consequence is that legitimate purchasing resembles ordinary reagent purchasing, with institutional procurement routes, purchase records and batch documentation. Anyone with a health question should speak to a GP or pharmacist, and suspected side effects from any medicine or unlicensed product can be reported through the MHRA Yellow Card scheme.
Purity, storage and handling
Reversed-phase HPLC is the foundational purity test. The peptide is separated on a hydrophobic stationary phase using a gradient of water and an organic solvent such as acetonitrile, usually with an ion-pairing acid, and detected by UV absorbance at 214 or 220 nm, where the peptide bond absorbs. The reported purity is the area of the main peak as a percentage of total peak area. That figure is meaningful only if the method is stated, the chromatogram is available and the gradient is shallow enough to resolve closely related impurities. A bare percentage with no trace is an assertion and not evidence.
HPLC must be paired with mass spectrometry, using electrospray ionisation or MALDI-TOF, to confirm that the dominant species has the expected molecular mass. A clean peak at the wrong mass is a clean peak of the wrong compound.
A batch-specific certificate of analysis converts these tests into usable evidence. It should carry a lot number matching the vial, the analytical method, the purity result, observed and theoretical masses, the test date and ideally the salt form, net peptide content and endotoxin result. A generic specification describes what a supplier intends, whereas a batch certificate records what was measured. Lyophilised powders contain counterions and water, so the weighed mass is not the mass of peptide, and ignoring this introduces systematic errors into every concentration calculation.
Because what peptides do in an assay depends on the material actually in the vial, and because degradation accelerates once a peptide is dissolved, a researcher asking what do peptides do in a given experiment should expect any source to provide a batch-specific certificate of analysis, lyophilised shipment in sealed vials and storage at -20°C on receipt, and the same documentation standard applies when weighing any best peptides supplier uk claim, since a supplier’s analytical record rather than its search ranking shows whether the vial matches its stated specification.
Lyophilised peptides are generally stored at -20°C, with -80°C often used for long-term archives, in a sealed container with desiccant and protected from light. Vials should reach room temperature before opening so that condensation does not form on the cold powder. Hygroscopic sequences absorb moisture quickly, and water drives hydrolysis.
After reconstitution, stability falls. Standard practice is to dissolve the peptide in sterile water or a buffer chosen for the sequence, divide the solution into single-use aliquots and freeze them, avoiding repeated freeze-thaw cycles. Refrigerated storage at 2 to 8°C may be acceptable for a few days in some cases, but the period should be validated for the assay, preferably by re-running HPLC on stored solution. Sequences rich in methionine, cysteine or tryptophan need particular care because of oxidation, and neutral to alkaline pH can accelerate deamidation.
Light sensitivity is a secondary but genuine concern. Aromatic residues can undergo photo-oxidation, so amber vials or dark storage are advisable. Low-bind tubes are preferable for dilute solutions, since peptides adsorb to some plastics and glass at low concentrations.
Laboratory safety follows ordinary chemical hygiene. The safety data sheet should be read before use, because many research peptides have not been fully toxicologically characterised. Gloves, a laboratory coat and eye protection are standard, lyophilised powder should be weighed in a ventilated enclosure, and institutional COSHH assessments should cover the material and procedure.
Frequently asked questions
What do peptides do in the body?
In biology, peptides act as hormones, neurotransmitters, growth factors and defence molecules, usually by binding receptors and triggering signalling. The function depends on the specific sequence. These are descriptions of natural biology and do not apply to unlicensed research products.
What do peptides do in laboratory research?
They are used as receptor ligands, enzyme substrates, antigens for antibody production, epitope sets in immunology and reference standards in mass spectrometry. Most work is done in cell culture, structural biology and analytical chemistry, with animal work only under Home Office authorisation.
How do peptides work at the receptor level?
Most peptide hormones bind G protein-coupled receptors on the cell surface, which activate intracellular G proteins and change levels of messengers such as cyclic AMP or calcium. In the laboratory, this response is measured to compare how potent different peptides are.
What should a research peptide come with?
A batch-specific certificate of analysis showing HPLC purity, mass spectrometry confirmation, a lot number matching the vial and the test date. Salt form, net peptide content and endotoxin results add further assurance, and a clear research-only label should be present.
All peptides referred to in this article are supplied for in-vitro laboratory research only and are not intended for human or veterinary use.
